EXPRESSION OF CHROMOGRANIN-A MESSENGER-RNA IN SMALL-CELL CARCINOMA OF THE LUNG

被引:24
作者
HAMID, Q
CORRIN, B
SHEPPARD, MN
HUTTNER, WB
POLAK, JM
机构
[1] BROMPTON HOSP, NATL HEART & LUNG INST, SYDNEY ST, LONDON SW3 6NP, ENGLAND
[2] EUROPEAN MOLEC BIOL LAB, W-6900 HEIDELBERG, GERMANY
[3] HAMMERSMITH HOSP, ROYAL POSTGRAD MED SCH, LONDON W12 0HS, ENGLAND
关键词
CHROMOGRANIN; MESSENGER RNA; GENE; SMALL CELL CARCINOMA; LUNG TUMORS; INSITU HYBRIDIZATION; IMMUNOCYTOCHEMISTRY;
D O I
10.1002/path.1711630405
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Chromogranin A (CgA) is the most specific neuroendocrine marker but in small cell carcinoma of the lung (SCCL) CgA immunoreactivity cannot always be detected, possibly owing to poor granularity. The localization of CgA mRNA could be a more useful indicator of CgA synthesis in SCCL. We have therefore studied the expression of CgA mRNA in SCCL, using in situ hybridization and Northern blot analysis, comparing it with CgA immunoreactivity. The expression of CgA mRNA and immunoreactivity in other types of lung tumours was also investigated. Freshly fixed, surgically resected SCCL (n = 5), adenocarcinoma (n = 10), squamous cell carcinoma (n = 10), large cell carcinoma (n = 5), and primary lymphoma (n = 2) were examined. Weak immunoreactivity to CgA was seen in one SCCL but all five strongly expressed CgA mRNA. The specificity of the in situ hybridization signal and the probe was confirmed by the use of a sense probe and Northern blot analysis. Non-SCCLs were negative for both CgA mRNA and immunoreactivity. This study provides evidence for CgA synthesis in SCCL and confirms the specificity of CgA for neuroendocrine differentiation. In situ hybridization appears to be a very useful tool for investigating the nature of tumour cells, especially in the absence of the end product of the gene transcript.
引用
收藏
页码:293 / 297
页数:5
相关论文
共 45 条
[1]   IMMUNOHISTOCHEMICAL MARKERS OF SMALL CELL-CARCINOMA AND RELATED NEUROENDOCRINE TUMORS OF THE LUNG [J].
ADDIS, BJ ;
HAMID, Q ;
IBRAHIMS, NBN ;
FAHEY, M ;
BLOOM, SR ;
POLAK, JM .
JOURNAL OF PATHOLOGY, 1987, 153 (02) :137-150
[2]  
BENSCH KG, 1968, CANCER, V22, P422
[3]   THE OCCURRENCE OF PANCREASTATIN IN TUMORS OF THE DIFFUSE NEURO-ENDOCRINE SYSTEM [J].
BISHOP, AE ;
BRETHERTONWATT, D ;
HAMID, QA ;
FAHEY, M ;
SHEPHERD, N ;
VALENTINO, K ;
TATEMOTO, K ;
GHATEI, MA ;
BLOOM, SR ;
POLAK, JM .
MOLECULAR AND CELLULAR PROBES, 1988, 2 (03) :225-235
[4]   SECRETION OF A CHROMAFFIN GRANULE PROTEIN CHROMOGRANIN FROM ADRENAL GLAND AFTER SPLANCHNIC STIMULATION [J].
BLASCHKO, H ;
COMLINE, RS ;
SCHNEIDER, FH ;
SILVER, M ;
SMITH, AD .
NATURE, 1967, 215 (5096) :58-+
[5]   SYNAPTOPHYSIN IMMUNOREACTIVITY AND SMALL CLEAR VESICLES IN NEURO-ENDOCRINE CELLS AND RELATED TUMORS [J].
BUFFA, R ;
RINDI, G ;
SESSA, F ;
GINI, A ;
CAPELLA, C ;
JAHN, R ;
NAVONE, F ;
DECAMILLI, P ;
SOLCIA, E .
MOLECULAR AND CELLULAR PROBES, 1987, 1 (04) :367-381
[6]   ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE [J].
CHIRGWIN, JM ;
PRZYBYLA, AE ;
MACDONALD, RJ ;
RUTTER, WJ .
BIOCHEMISTRY, 1979, 18 (24) :5294-5299
[7]   A CLONED CHROMOGRANIN-A (CGA) CDNA DETECTS A 2.3KB MESSENGER-RNA IN DIVERSE NEUROENDOCRINE TISSUES [J].
DEFTOS, LJ ;
MURRAY, SS ;
BURTON, DW ;
PARMER, RJ ;
OCONNOR, DT ;
DELEGEANE, AM ;
MELLON, PL .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 137 (01) :418-423
[8]  
DEFTOS LJ, 1988, CANCER, V62, P92, DOI 10.1002/1097-0142(19880701)62:1<92::AID-CNCR2820620117>3.0.CO
[9]  
2-T
[10]   NEURAL MARKERS IN CARCINOMA OF THE LUNG [J].
DHILLON, AP ;
RODE, J ;
DHILLON, DP ;
MOSS, E ;
THOMPSON, RJ ;
SPIRO, SG ;
CORRIN, B .
BRITISH JOURNAL OF CANCER, 1985, 51 (05) :645-652